Delivery Order SPE2DB22D1202-SPE2DB24FVMS9
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order worth $12,739.86 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp under an Indefinite Delivery Contract (IDC) for the supply of 100mg vials of the biologic drug Remicade. The ultimate completion date for this delivery order is September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and federal healthcare programs. The contract does not have...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,029.28 firm fixed-price contract is for the delivery of 100 mg vials of the medication Remicade. The contract has a completion date of June 25, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of 100 mg vials of the drug Remicade. The $16,164.44 firm fixed-price contract runs through October 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $10,024.40 firm fixed price delivery order is for the supply of Remicade 100 mg vials, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,568.80 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg vials of the drug Remicade. The contract has an ultimate completion date of September 4, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMICADE 100 MG VIALS. The contract has a ceiling value of $35,458.10 and is a firm fixed price delivery order that runs through August 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $10,817.60 firm-fixed-price contract is for the supply of 100mg vials of the pharmaceutical product Remicade. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, has been awarded numerous Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,275.20 firm fixed-price delivery order is for the supply of REMICADE 100 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,518.30, is for the delivery of 4,568,139,088 units of the medication Remicade (100 mg vials). The contract is a Firm Fixed Price delivery order, with a performance period extending through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) awarded a $34,436.74 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of 4565677215 REMICADE 100 MG VIALS. This contract, which does not have a set-aside designation, has a period of performance through September 5, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with the...